PRESS CENTRE/LATEST INFORMATION
All information on our Company’s activities in one place

News

PRESS CENTRE / NEWS
Bosnalijek breaks its own business records
The largest domestic pharmaceutical company, Bosnalijek j.s.c., in the first nine months of 2022, achieved total revenue of 120.5 million BAM and thereby achieved revenue growth of 33.4 million BAM or 38 percent compared to the same period last year.
MORE
PRESS CENTRE / NEWS
Bosnalijek breaks its own business records
The largest domestic pharmaceutical company, Bosnalijek j.s.c., in the first nine months of 2022, achieved total revenue of 120.5 million BAM and thereby achieved revenue growth of 33.4 million BAM or 38 percent compared to the same period last year.
Read more
PRESS CENTAR / NEWS
Record semi-annual performance of Bosnalijek in 2022
In the first half of 2022, Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, made record profit before tax of BAM 20.7 million, an increase by BAM 18.9 million compared to the same period of the previous year. The profit is the result of the successfully implemented strategy and activities of the management and employees of Bosnalijek.
Read more
Previous news
NOTICE OF CONVENING ANNUAL REGULAR ASSEMBLY OF BOSNALIJEK JSC Notice on re-convening Regular Annual Shareholders Assembly of Bosnalij ... NOTICE ON CONVENING ANNUAL REGULAR ASSEMBLY OF BOSNALIJEK JSC NOTICE ON CONVENING AN EXTRAORDINARY SESSION OF THE GENERAL ASSEMBLY OF ... Notice on reconvening of regular annual shareholders’ Assembly of Bosnal ... Notice of convening annual regular assembly of Bosnalijek joint stock co ... REPORT BY VOTING COMMITTEE Notice of convening annual regular assembly of Bosnalijek d.d. Bosnalijek Opens New Facility for Manufacturing Liquid and Semisolid Pha ... Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race ... Notice of convening annual regular assembly of Bosnalijek joint stock co ... Professional Lecture for Doctors and Patients Held On the Occasion of th ... Bosnalijek signs cooperation agreement with Mylan, a global healthcare c ... Bosnalijek Appoints US Major General David L. Grange (Ret.) as the Board ... The Third Congress of Pharmacists from Montenegro held in Bečići Foreign markets recognize the quality of our products Bosnalijek won the prestigious industry award Bosnalijek is again the best employer in the pharmaceutical sector in 20 ... Successful Two-Day Roundtable of Psychiatrists Held “Global Enterofuryl® Speaker Training – GEST” conference gathers nationa ...
decembar 06. 2022 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%